corticosterone has been researched along with Dyslipidemia in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with COC led to elevated fasting blood glucose, insulin, corticosterone, triglycerides (TG), TG/HDL-cholesterol ratio, insulin resistance (IR) and impaired glucose tolerance." | 7.83 | Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone. ( Kim, I; Olatunji, LA; Omolekulo, TE; Usman, TO, 2016) |
| "Corticosterone treatment significantly increased atherosclerotic plaque area at the aortic root." | 5.40 | Corticosterone accelerates atherosclerosis in the apolipoprotein E-deficient mouse. ( Higashida, K; Higuchi, M; Lira, VA; Okutsu, M; Peake, J; Suzuki, K, 2014) |
| " Here we reported that long-term corticosterone (CORT) exposure in mice induced weight gain, dyslipidemia as well as hyperglycaemia and systemic insulin resistance." | 3.91 | Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration. ( Bruno, F; Do, TTH; Guillaume, D; Héloïse, D; Marie, G; Marion, B; Marthe, M, 2019) |
| "These results demonstrates that hypertension and insulin resistance induced by COC is associated with increased cardiac RAS and PAI-1 gene expression, which is likely to be through corticosterone-dependent but not aldosterone-dependent mechanism." | 3.85 | Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder. ( Kim, IK; Olatunji, LA; Seok, YM; Usman, TO, 2017) |
| "Treatment with COC led to elevated fasting blood glucose, insulin, corticosterone, triglycerides (TG), TG/HDL-cholesterol ratio, insulin resistance (IR) and impaired glucose tolerance." | 3.83 | Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone. ( Kim, I; Olatunji, LA; Omolekulo, TE; Usman, TO, 2016) |
| " Using a mouse model of excess corticosterone exposure, we found that the ability of glucocorticoids to increase adiposity, weight gain, hormonal dysregulation, hepatic steatosis, and dyslipidemia was reduced or reversed in mice lacking the cannabinoid CB1 receptor as well as mice treated with the global CB1 receptor antagonist AM251." | 3.81 | A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome. ( Bowles, NP; Hill, MN; Hillard, CJ; Karatsoreos, IN; Kunos, G; Li, X; Li, Z; Makriyannis, AM; McEwen, BS; Schwartz, GJ; Tamashiro, KL; Vemuri, VK; Wood, JA, 2015) |
| "Experiments on rats with myocardial ischemia modeled by occlusion of the left coronary artery aggravated by alimentary dislipoproteinemia showed that therapy with taurepar (50 mg/kg), a taurine derivative, decreased blood corticosterone concentration and increased the level of endogenous testosterone, which attests to normalization of the compensatory-adaptive and gonadotropic functions of the organism." | 3.76 | Pharmacological correction of testosterone deficiency during experimental myocardial ischemia. ( Fedotova, YO; Khnychenko, LK; Okunevich, IV; Sapronov, NS, 2010) |
| "Corticosterone treatment significantly increased atherosclerotic plaque area at the aortic root." | 1.40 | Corticosterone accelerates atherosclerosis in the apolipoprotein E-deficient mouse. ( Higashida, K; Higuchi, M; Lira, VA; Okutsu, M; Peake, J; Suzuki, K, 2014) |
| "Metabolic syndrome is a condition that typically includes central obesity, insulin resistance, glucose intolerance, dyslipidemia, and hypertension." | 1.38 | Anatomic, hematologic, and biochemical features of C57BL/6NCrl mice maintained on chronic oral corticosterone. ( Cassano, AE; Karatsoreos, IN; Penraat, KA; Rasmussen, S; White, JR; Wilson, CD, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Do, TTH | 1 |
| Marie, G | 1 |
| Héloïse, D | 1 |
| Guillaume, D | 1 |
| Marthe, M | 1 |
| Bruno, F | 1 |
| Marion, B | 1 |
| Higashimoto, M | 1 |
| Isoyama, N | 1 |
| Ishibashi, S | 1 |
| Ogawa, N | 1 |
| Takiguchi, M | 1 |
| Suzuki, S | 1 |
| Ohnishi, Y | 1 |
| Sato, M | 1 |
| Okutsu, M | 1 |
| Lira, VA | 1 |
| Higashida, K | 1 |
| Peake, J | 1 |
| Higuchi, M | 1 |
| Suzuki, K | 1 |
| Bowles, NP | 1 |
| Karatsoreos, IN | 2 |
| Li, X | 1 |
| Vemuri, VK | 1 |
| Wood, JA | 1 |
| Li, Z | 1 |
| Tamashiro, KL | 1 |
| Schwartz, GJ | 1 |
| Makriyannis, AM | 1 |
| Kunos, G | 1 |
| Hillard, CJ | 1 |
| McEwen, BS | 1 |
| Hill, MN | 1 |
| Olatunji, LA | 2 |
| Omolekulo, TE | 1 |
| Usman, TO | 2 |
| Kim, I | 1 |
| Seok, YM | 1 |
| Kim, IK | 1 |
| Khnychenko, LK | 1 |
| Okunevich, IV | 1 |
| Fedotova, YO | 1 |
| Sapronov, NS | 1 |
| Cassano, AE | 1 |
| White, JR | 1 |
| Penraat, KA | 1 |
| Wilson, CD | 1 |
| Rasmussen, S | 1 |
8 other studies available for corticosterone and Dyslipidemia
| Article | Year |
|---|---|
Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipocytes; Adipose Tissue; Animals; Carbohydrate Dehyd | 2019 |
Preventive effects of metallothionein against DNA and lipid metabolic damages in dyslipidemic mice under repeated mild stress.
Topics: Adiponectin; Animals; Carnitine; Corticosterone; Diet, High-Fat; DNA Damage; Dyslipidemias; Female; | 2013 |
Corticosterone accelerates atherosclerosis in the apolipoprotein E-deficient mouse.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Chemokine CCL2; Corticosterone; Cytokines; Dyslipidemia | 2014 |
A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome.
Topics: Animals; Corticosterone; Dyslipidemias; Endocannabinoids; Glucocorticoids; Liver; Metabolic Syndrome | 2015 |
Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone.
Topics: Animals; Anticonvulsants; Contraceptives, Oral, Combined; Corticosterone; Dyslipidemias; Female; Glu | 2016 |
Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder.
Topics: Aldosterone; Animals; Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Contraceptive | 2017 |
Pharmacological correction of testosterone deficiency during experimental myocardial ischemia.
Topics: Animals; Corticosterone; Dietary Fats; Dyslipidemias; Male; Myocardial Ischemia; Rats; Taurine; Test | 2010 |
Anatomic, hematologic, and biochemical features of C57BL/6NCrl mice maintained on chronic oral corticosterone.
Topics: Adrenal Glands; Analysis of Variance; Animals; Case-Control Studies; Corticosterone; Dose-Response R | 2012 |